Latest Ratios: P/E Ratio -0.4x · EV/EBITDA N/A · ROE -67.6%. (2008–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $29M | $58M | $85M | $81M | $367M | $541M | $103M | $194M | $1.8B | — | — |
| Enterprise Value | $4M | $34M | $45M | $-57436864 | $131M | $285M | $40M | $183M | $1.8B | — | — |
| P/E Ratio → | -0.36 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | — | — | — | — | 14.70 | 55.64 | 5.74 | 194.54 | 219.78 | — | — |
| P/B Ratio | 0.13 | 0.36 | 0.45 | 0.48 | 1.26 | 1.79 | 0.94 | — | 17.25 | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | — | — | — | 5.23 | 29.27 | 2.24 | 183.88 | 219.30 | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | 100.0% | 100.0% | 100.0% | 100.0% | 99.0% | 100.0% | 24.8% |
| Operating Margin | — | — | — | — | -290.3% | -631.4% | -218.9% | -3154.6% | -182.9% | -3.4% | -0.0% |
| Net Profit Margin | — | — | — | — | -279.3% | -637.2% | -204.9% | -2827.9% | -113.7% | -6.0% | -0.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -67.6% | -67.6% | -65.7% | -61.7% | -23.4% | -30.0% | -148.3% | -128.4% | -12.1% | -19.1% | -0.0% |
| ROA | -56.6% | -56.6% | -54.8% | -53.0% | -20.8% | -25.2% | -31.2% | -29.4% | -11.3% | -11.3% | -0.0% |
| ROIC | -64.9% | -64.9% | -107.1% | -261.9% | -106.4% | -98.4% | -62.4% | -160.7% | -5.0% | -4.0% | -0.0% |
| ROCE | -65.7% | -65.7% | -65.6% | -60.9% | -22.9% | -27.1% | -39.6% | -36.7% | -19.4% | -7.7% | -0.0% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.09 | 0.09 | 0.09 | 0.12 | 0.07 | 0.07 | 0.20 | — | 0.03 | 7.12 | 0.39 |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | 10.03 |
| Net Debt / Equity | — | -0.15 | -0.21 | -0.82 | -0.81 | -0.85 | -0.57 | — | -0.04 | 6.04 | 0.17 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | 4.39 |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | 6.73 |
| Interest Coverage | -3243.53 | -3243.53 | -29279.50 | -5705.32 | -871.38 | -351.98 | -293.72 | — | — | -4.83 | -0.00 |
Net cash position: cash ($39M) exceeds total debt ($15M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.47 | 7.47 | 9.29 | 8.41 | 13.25 | 17.31 | 4.46 | 4.32 | 19.16 | 9.86 | 3.57 |
| Quick Ratio | 7.47 | 7.47 | 9.29 | 8.41 | 13.25 | 17.31 | 4.46 | 4.32 | 19.16 | -14.93 | 2.57 |
| Cash Ratio | 7.36 | 7.36 | 9.09 | 8.28 | 13.07 | 17.01 | 4.21 | 4.20 | 18.90 | 9.70 | 0.68 |
| Asset Turnover | — | — | — | — | 0.08 | 0.03 | 0.12 | 0.01 | 0.07 | 10.12 | 1.01 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | 0.00 | 4.19 |
| Days Sales Outstanding | — | — | — | — | 6.35 | 8.03 | 55.68 | 342.99 | — | — | 111.85 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $7M | $5M | $3M | $3M | $2M | $457499 | $1M | $2M | $2M | $2M |
Includes 30+ ratios · 18 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ACET stock.
Adicet Bio, Inc.'s current P/E ratio is -0.4x. This places it at the 50th percentile of its historical range.
Adicet Bio, Inc.'s return on equity (ROE) is -67.6%. The historical average is -26.9%.
Based on historical data, Adicet Bio, Inc. is trading at a P/E of -0.4x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.